Aims & Scope – Endocrine, Metabolic & Immune Disorders – Drug Targets

Aims & Scope:

This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.

 

 

For more details, please visit: https://benthamscience.com/journals/endocrine-metabolic-and-immune-disorders-drug-targets/aims-scope/#top

UPCOMING THEMATIC ISSUE

Thematic Issue Proposal Approved For May 2015 on “METABOLIC TARGETING OF CANCERS”

A thematic issue proposal entitled “Metabolic targeting of cancers” has been approved for proposal Recent Patents on Anti-Cancer Drug Discovery. The issue will be published in 2015 issue.

For details on this journal, click: http://benthamscience.com/journal/index.php?journalID=rpacdd